Healthcare sector | Medical Instruments & Supplies industry
| Price | $7.51 |
|---|---|
| Shares Outstanding | 682.06M |
| All-Time Low | $6.66 |
| 52-Week Low | $8.89 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-5.54 |
| Net Tangible Assets / Share | $0 |
| Shares Outstanding Ave Change (Annual) | 0.38% |
| Shares Δ YoY | 0.18% |
| Avg CA Burn (Annual %) | -2.02% (as of 2-20-2026) |
| Avg CA Burn (Quarterly %) | 3.71% (as of 2-20-2026) |
| Max Earning Power / Share | $3.13 |
|---|---|
| Adjusted Earning Power |
$0.73
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.91%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 1.1B (as of 2-20-2026) |
| Avg EBITDA (5Q) | 281.9M (as of 2-20-2026) |
| Avg Net Income (5Y) | 297.2M (as of 2-20-2026) |
| Avg Net Income (5Q) | -6M (as of 2-20-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 2-20-2026 |
| Consecutive Years Paid | No | 2-20-2026 |
| Pays Dividend | No | 2-20-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 2-20-2026 |
| Net Income Positive | Yes | 2-20-2026 |
| Current Dividend Streak | No | 2-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $-3.84 | -2.6B ($-2,615,700,000) | 682M (682,000,000) |
| 2025-12-31 | Annual | $-3.84 | -2.6B ($-2,615,700,000) | 682M (682,000,000) |
| 2025-09-30 | Quarterly | $-3.93 | -2.7B ($-2,681,200,000) | 681.9M (681,900,000) |
| 2025-06-30 | Quarterly | $-4.15 | -2.8B ($-2,826,500,000) | 681.6M (681,600,000) |
| 2025-03-31 | Quarterly | $-4.17 | -2.8B ($-2,842,000,000) | 681.5M (681,500,000) |
| 2024-12-31 | Quarterly | $-4.32 | -2.9B ($-2,942,400,000) | 680.8M (680,800,000) |
| 2024-12-31 | Annual | $-4.32 | -2.9B ($-2,942,400,000) | 680.8M (680,800,000) |
| 2023-12-31 | Annual | $-6.27 | -4.2B ($-4,239,400,000) | 676.6M (676,600,000) |
| 2022-12-31 | Annual | $-7.31 | -4.9B ($-4,930,500,000) | 674.3M (674,300,000) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2025-12-31 | 6.6B ($6,552,200,000) |
| 2024-12-31 | 6.8B ($6,783,600,000) |
| 2023-12-31 | 7B ($6,967,200,000) |
| 2022-12-31 | 7.5B ($7,512,400,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-02-13 | 682,055,932 | +241,073 |
Latest short-interest change: 39,218,288 shares (7.83% of float) | Days to cover: 2.88
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-11 | 39,218,288 shares | -655,238 | -1.64% |
| 2026-02-26 | 39,873,526 shares | +2,162,867 | +5.74% |
| 2026-02-11 | 37,710,659 shares | +7,613,590 | +25.30% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.